News Articles
Latest articles, insights, and updates from the blog.
Contact Ketamine Troche
Send corrections, provider questions, or advertising inquiries.
Federal Officials Probe Online Ketamine Sellers
Federal officials are investigating online ketamine sellers to limit at-home use. Here's what troche patients and telehealth ketamine users need to know.
FDA Moves Against Illegal Ketamine Sellers in 2026
The FDA is targeting illegal ketamine sellers in 2026. Here's what this enforcement action means for patients using compounded ketamine troches.
Ketamine Research: Hope for Resistant Depression Patients
New research highlights ketamine's rapid antidepressant effects in treatment-resistant depression and suicidal ideation — what troche patients need to know.
Esketamine Nasal Spray vs. Troches: What TRD Data Shows
Psychiatric Times reviews esketamine nasal spray safety for TRD and MDD — key findings and what ketamine troche patients should know.
Non-Drug Approaches Boost Ketamine Troche Outcomes
New research explores how behavioral therapy and neuroplasticity techniques can enhance ketamine troche treatment outcomes for depression.
Expert Insights: Key Ketamine Patient Considerations
Dr. Benjamin Brody highlights critical patient considerations for ketamine treatment at ASCP 2026, with key implications for troche therapy protocols.
Boston Clinics Spotlight Ketamine's Mental Health Role
Boston-area clinics are spotlighting ketamine for depression and anxiety. Here's what their approach means for patients using at-home ketamine troches.
TMS vs. Ketamine: What TRD Patients Should Know
Medical Daily covers when to try ketamine or TMS for treatment-resistant depression. Here's what it means for patients weighing ketamine troches.
IV Ketamine in the News: What Troche Users Should Know
A FOX 4 Kansas City segment spotlights IV ketamine therapy. Here's what the growing media attention means for ketamine troche patients and at-home access.
Ketamine & Workers' Comp: What Alabama's Rules Mean
Alabama workers' comp cases are testing ketamine therapy coverage standards. Here's what this legal shift means for troche access and reimbursement in 2026.
Esketamine Clinic Protocols: What Troche Patients Should Know
New esketamine clinic-protocol guidance shows why sublingual ketamine troches stay a flexible, accessible alternative for many treatment-resistant patients.
NMDA Side Effects: What the Data Means for Troche Users
New research on NMDA antagonist side effects and discontinuation rates offers practical guidance for ketamine troche patients managing treatment-resistant depression.
Ketamine Dropout Rates: The Case for Troche Optimization
New clinical data on NMDA antagonist side effects and dropout rates reveals why troche dosing flexibility may improve long-term treatment adherence.